The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pet Vaccine Market Research Report 2025

Global Pet Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1806539

No of Pages : 89

Ask Your Query

Report Description
Table of Content

Synopsis

The global Pet Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Pet Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pet Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Pet Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pet Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Vaccine.

Report Scope

The Pet Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)

Segment by Type

Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines

Segment by Application

Canine
Avian
Feline

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Pet Vaccine Market Overview
1.1 Product Overview and Scope of Pet Vaccine
1.2 Pet Vaccine Segment by Type
1.2.1 Global Pet Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Pet Vaccine Segment by Application
1.3.1 Global Pet Vaccine Market Value by Application: (2024-2030)
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Global Pet Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pet Vaccine Revenue 2019-2030
1.4.2 Global Pet Vaccine Sales 2019-2030
1.4.3 Global Pet Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Vaccine Market Competition by Manufacturers
2.1 Global Pet Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pet Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Vaccine, Product Type & Application
2.7 Pet Vaccine Market Competitive Situation and Trends
2.7.1 Pet Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Vaccine Players Market Share by Revenue
2.7.3 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Vaccine Retrospective Market Scenario by Region
3.1 Global Pet Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Vaccine Global Pet Vaccine Sales by Region: 2019-2030
3.2.1 Global Pet Vaccine Sales by Region: 2019-2024
3.2.2 Global Pet Vaccine Sales by Region: 2025-2030
3.3 Global Pet Vaccine Global Pet Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pet Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pet Vaccine Revenue by Region: 2025-2030
3.4 North America Pet Vaccine Market Facts & Figures by Country
3.4.1 North America Pet Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Vaccine Sales by Country (2019-2030)
3.4.3 North America Pet Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Vaccine Market Facts & Figures by Country
3.5.1 Europe Pet Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pet Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pet Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pet Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Vaccine Sales by Type (2019-2030)
4.1.1 Global Pet Vaccine Sales by Type (2019-2024)
4.1.2 Global Pet Vaccine Sales by Type (2025-2030)
4.1.3 Global Pet Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pet Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pet Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pet Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pet Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pet Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Vaccine Sales by Application (2019-2030)
5.1.1 Global Pet Vaccine Sales by Application (2019-2024)
5.1.2 Global Pet Vaccine Sales by Application (2025-2030)
5.1.3 Global Pet Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pet Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pet Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pet Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pet Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pet Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Pet Vaccine Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetoquinol S.A Pet Vaccine Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Pet Vaccine Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Pet Vaccine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska Co.
6.6.1 Heska Co. Corporation Information
6.6.2 Heska Co. Description and Business Overview
6.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heska Co. Pet Vaccine Product Portfolio
6.6.5 Heska Co. Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Pet Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merial (Sanofi) Pet Vaccine Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Virbac Pet Vaccine Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Zoetis (Pfizer)
6.10.1 Zoetis (Pfizer) Corporation Information
6.10.2 Zoetis (Pfizer) Description and Business Overview
6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zoetis (Pfizer) Pet Vaccine Product Portfolio
6.10.5 Zoetis (Pfizer) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Vaccine Industry Chain Analysis
7.2 Pet Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Vaccine Production Mode & Process
7.4 Pet Vaccine Sales and Marketing
7.4.1 Pet Vaccine Sales Channels
7.4.2 Pet Vaccine Distributors
7.5 Pet Vaccine Customers
8 Pet Vaccine Market Dynamics
8.1 Pet Vaccine Industry Trends
8.2 Pet Vaccine Market Drivers
8.3 Pet Vaccine Market Challenges
8.4 Pet Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}